CXDC [China XD Plastics Co] 10-Q/A: (Original Filing)

[Explanatory Note · Part I, Item 1- Condensed Consolidated Financial Statements (Unaudited) Notes to the Condensed Consolidated Financial Statements (Unaudited) · Part I, Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations. The restatements are related to accounting errors identified in (1) the Company’s condensed consolidated statements of cash flows and (2) calculation of basic and] [CERTIFICATION I, Jie Han, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Taylor Zhang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION Jie Han, Chief Executive Officer] [CERTIFICATION Taylor Zhang, Chief Financial Officer]

By | 2016-03-25T16:23:35+00:00 November 2nd, 2011|Categories: Chinese Stocks, CXDC, SEC Original|Tags: , , , , , |0 Comments

CXDC [China XD Plastics Co] 10-Q/A: Explanatory Note · Part I, Item 1- Condensed

[Explanatory Note · Part I, Item 1- Condensed Consolidated Financial Statements (Unaudited) Notes to the Condensed Consolidated Financial Statements (Unaudited) · Part I, Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations. The restatements are related to accounting errors identified in (1) the Company’s condensed consolidated statements of cash flows and (2) calculation of basic and] [CERTIFICATION I, Jie Han, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Taylor Zhang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION Jie Han, Chief Executive Officer] [CERTIFICATION Taylor Zhang, Chief Financial Officer]

By | 2016-03-25T16:24:52+00:00 November 2nd, 2011|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q/A: Explanatory Note This Form 10-Q/A should be read

[Explanatory Note This Form 10-Q/A should be read innjunction with the original Form 10-Q, whichntinues toeak of thete of the Form 10-Q. Exceptecifically notedove, this Form 10-Q/A does not modify or update disclosures in the original Form 10-Q. Accordingly, this Form 10-Q/A does not reflect events occurring after the filing of the Form 10-Q or]

By | 2016-02-05T03:29:26+00:00 September 21st, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q/A: (Original Filing)

[FORM 10-Q/A Amendment No.1 (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including]

By | 2016-03-03T19:09:27+00:00 September 6th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q/A: FORM 10-Q/A Amendment No.1 (Mark One) x June

[FORM 10-Q/A Amendment No.1 (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including]

By | 2016-03-03T19:10:27+00:00 September 6th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q/A: FORM 10-Q/A Amendment No.1 (Mark One) x June

[FORM 10-Q/A Amendment No.1 (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216]

By | 2016-02-07T22:47:31+00:00 September 6th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar